Unraveling the antitrypanosomal mechanism of benznidazole and related 2‐nitroimidazoles: From prodrug activation to DNA damage
- 1 June 2021
- journal article
- research article
- Published by Wiley in Molecular Microbiology
- Vol. 116 (2), 674-689
- https://doi.org/10.1111/mmi.14763
Abstract
Nitroheterocycles represent an important class of compound used to treat trypanosomiasis. They often function as prodrugs and can undergo type I nitroreductase (NTR1)-mediated activation before promoting their anti-parasitic activities although the nature of these downstream effects has yet to be determined. Here, we show that in an NTR1-dependent process, benznidazole promotes DNA damage in the nuclear genome of Trypanosoma brucei, providing the first direct link between activation of this prodrug and a downstream trypanocidal mechanism. Phenotypic and protein expression studies revealed that components of the trypanosome’s homologous recombination (HR) repair pathway (TbMRE11, γH2A, TbRAD51) cooperate to resolve the benznidazole-induced damage, indicating that the prodrug-induced lesions are most likely double stand DNA breaks, while the sequence/recruitment kinetics of these factors parallels that in other eukaryotes HR systems. When extended to other NTR1-activated 2-nitroimidazoles, some were shown to promote DNA damage. Intriguingly, the lesions induced by these required TbMRE11 and TbCSB activities to fix leading us to postulate that TbCSB may operate in systems other than the transcription-coupled nucleotide excision repair pathway. Understanding how existing trypanosomal drugs work will aid future drug design and help unlock novel reactions/pathways that could be exploited as targets for therapeutic intervention.Funding Information
- Queen Mary University of London
- Islamic Development Bank
This publication has 62 references indexed in Scilit:
- Nucleotide excision repair–initiating proteins bind to oxidative DNA lesions in vivoThe Journal of cell biology, 2012
- Trypanosomal histone γH2A and the DNA damage responseMolecular and Biochemical Parasitology, 2012
- Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single PopulationThe Journal of Infectious Diseases, 2012
- High-throughput decoding of antitrypanosomal drug efficacy and resistanceNature, 2012
- Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal FormationAntimicrobial Agents and Chemotherapy, 2012
- Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile MetabolitesOnline Journal of Public Health Informatics, 2011
- Analysis of the Trypanosoma brucei cell cycle by quantitative DAPI imagingMolecular and Biochemical Parasitology, 2008
- The role of Cockayne Syndrome group B (CSB) protein in base excision repair and agingMechanisms of Ageing and Development, 2008
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomesProceedings of the National Academy of Sciences of the United States of America, 2008
- Deletion of the Trypanosoma brucei Superoxide Dismutase Gene sodb1 Increases Sensitivity to Nifurtimox and BenznidazoleAntimicrobial Agents and Chemotherapy, 2007